Early imaging marker of progressing glioblastoma: a window of opportunity-Reference-Cited by-同舟云学术

Early imaging marker of progressing glioblastoma: a window of opportunity

Published:2020-06-29 Issue:3 Volume:148 Page:629-640
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Gatson Na Tosha N.^ORCID,Bross Shane P.,Odia Yazmin^ORCID,Mongelluzzo Gino J.^ORCID,Hu Yirui^ORCID,Lockard Laura,Manikowski Jesse J.,Mahadevan Anand^ORCID,Kazmi Syed A. J.^ORCID,Lacroix Michel^ORCID,Conger Andrew R.^ORCID,Vadakara Joseph^ORCID,Nayak Lakshmi,Chi T. Linda^ORCID,Mehta Minesh P.^ORCID,Puduvalli Vinay K.^ORCID

Funder

Geisinger Health System Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-020-03565-x.pdf

Reference49 articles.

1. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

2. Gilbert MR, Wang M, Aldape KD et al (2013) Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial. J Clin Oncol 31(32):4085–4091

3. Gorlia T, Stupp R, Brandes AA et al (2012) New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC brain tumor group phase I and II clinical trials. Eur J Cancer 48(8):1176–1184

4. Ortega A, Sarmiento JM, Ly D et al (2016) Multiple resections and survival of recurrent glioblastoma patients in the temozolomide era. J Clin Neurosci 24:105–111

5. Wann A, Tully PA, Barnes EH et al (2018) Outcomes after second surgery for recurrent glioblastoma: a retrospective case–control study. J Neuro-Oncol 137(2):409–415

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and predictive impact of abnormal signal volume evolution early after chemoradiotherapy in glioblastoma;Journal of Neuro-Oncology;2023-03-29

2. T2/FLAIR Abnormity Could be the Sign of Glioblastoma Dissemination;Frontiers in Neurology;2022-02-02